100 KING STREET WEST, TORONTO, A6
Reports Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 for October 2026
Reports Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934
Changes Name from Cybin Inc. to Helus Pharma Inc.
Announces Completion of Legal Name Change
To Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
To Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
To Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Amended Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
No filings found
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Supplemental Filing
Free Writing Prospectus
Registration Statement for Securities of Certain Canadian Issuers
Appointment of Agent for Service of Process by Foreign Banks and Foreign Insurance Companies